A German manufacturer specialising in wind turbines has opened an office in Melbourne to take advantage of growing demand across Victoria.
A French biopharmaceutical company will open a branch office in Melbourne because of the city’s excellent clinical trials development capabilities.
Melbourne medtech startup CNSDose is leading the way in genetically-guided dosing for the treatment of depression.
AusBiotech has signed an international partnership agreement with Japan’s peak body in regenerative medicine.
A Melbourne medical device company is putting Australia on the biomedical map for its ability to produce 3D printed parts for special applications.
Australians are the most tolerant and welcoming people on earth when it comes to migrants, according to renowned Melbourne demographer and futurist, Bernard Salt.
Twenty companies will share in almost A$30 million in funding to establish and expand advanced manufacturing activities in Victoria and South Australia, to be allocated under the Federal Advanced Manufacturing Growth Fund.
A new delivery system has been developed to target macular degeneration, by using a special drug that responds to shining light into the eye.
Melbourne has been identified as the fifth safest city in the world by the 2017 Safe Cities Index, a report from The Economist Intelligence Unit.
A new 30-minute test for coronary artery disease has been devised which reduces the number of invasive tests required to confirm diagnosis.
The new A$2.5 million Centre for Research Excellence in Malaria Elimination based at the Peter Doherty Institute for Infection and Immunity at the University of Melbourne is set to develop new drugs to treat the tropical scourge of malaria as well as train the next generation of experts in Australia and overseas to treat the persistent disease.
Highlighting the growing relationship between Victoria and Chile, the first direct flight between Santiago and Melbourne has landed at Tullamarine.